Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd CVALF


Primary Symbol: V.COV

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold... see more

Recent & Breaking News (TSXV:COV)

Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference

Business Wire October 30, 2024

Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting

Business Wire September 27, 2024

Covalon Announces Successful Warrant Redemption from 2019 Private Placement

Business Wire September 23, 2024

Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST

Accesswire September 19, 2024

Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference

Business Wire September 11, 2024

Covalon Announces Strong Third Quarter Fiscal 2024 Results

Business Wire August 21, 2024

Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2024 Financial Results

Business Wire August 14, 2024

Covalon Announces Profitable Second Quarter Fiscal 2024 Results

Business Wire May 29, 2024

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial Results

Business Wire May 22, 2024

Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO

Business Wire May 17, 2024

Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders

Business Wire March 7, 2024

Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024

Business Wire February 28, 2024

Covalon Announces First Quarter Fiscal 2024 Results

Business Wire February 28, 2024

Covalon Announces Management Changes

Business Wire January 26, 2024

Covalon Announces Fourth Quarter and Year End Results for Fiscal 2023

Business Wire January 26, 2024

Covalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO

Business Wire January 4, 2024

Covalon's VALGuard Gains Prestigious Recognition in the British Journal of Nursing

Business Wire November 15, 2023

Covalon Announces Issuance of Deferred Share Units

Business Wire October 20, 2023

Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR

Business Wire October 13, 2023

Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago

Business Wire October 11, 2023